Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide

被引:188
作者
Vandal, K [1 ]
Rouleau, P [1 ]
Boivin, A [1 ]
Ryckman, C [1 ]
Talbot, M [1 ]
Tessier, PA [1 ]
机构
[1] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Ctr Rech Infectiol, Ste Foy, PQ G1V 4G2, Canada
关键词
D O I
10.4049/jimmunol.171.5.2602
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recently, proinflammatory activities had been described for S100A8 and S100A9, two proteins found at inflammatory sites and within the neutrophil cytoplasm. In this study, we investigated the role of these proteins in neutrophil migration in vivo in response to LPS. LPS was injected into the murine air pouch, which led to the release of S100A8, S100A9, and S100A8/A9 in the pouch exudates that preceded accumulation of neutrophils. Passive immunization against S100A8 and S100A9 led to a 52% inhibition of neutrophil migration in response to LPS it 3 h postinjection. Injection of LPS was also associated with an increase in peripheral blood neutrophils and the presence in serum of S100A9 and S100A8/A9. Intravenous injection of S100A8, S100A9, or S100A8/A9 augmented the number of circulating neutrophils and diminished the number of neutrophils in the bone marrow, demonstrating that S100A8 and S100A9 induced the mobilization of neutrophils from the bone marrow to the blood. Finally, passive immunization with anti-S100A9 inhibited the neutrophilia associated with LPS injection in the air pouch. These results suggest that S100A8 and S100A9 play a role in the inflammatory response to LPS by inducing the release of neutrophils from the bone marrow and directing their migration to the inflammatory site.
引用
收藏
页码:2602 / 2609
页数:8
相关论文
共 50 条
[1]   IDENTIFICATION OF CYSTIC-FIBROSIS PROTEIN AS A COMPLEX OF 2 CALCIUM-BINDING PROTEINS PRESENT IN HUMAN-CELLS OF MYELOID ORIGIN [J].
BARTHE, C ;
FIGARELLA, C ;
CARRERE, J ;
GUYCROTTE, O .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (02) :175-177
[2]   Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells [J].
Bertini, R ;
Howard, OMZ ;
Dong, HF ;
Oppenheim, JJ ;
Bizzarri, C ;
Sergi, R ;
Caselli, G ;
Pagliei, S ;
Romines, B ;
Wilshire, JA ;
Mengozzi, M ;
Nakamura, H ;
Yodoi, J ;
Pekkari, K ;
Gurunath, R ;
Holmgren, A ;
Herzenberg, LA ;
Herzenberg, LA ;
Ghezzi, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1783-1789
[3]  
BRANDTZAEG P, 1995, ADV EXP MED BIOL, V371, P201
[4]  
BRUN JG, 1992, J RHEUMATOL, V19, P859
[5]  
Chen W, 1999, J IMMUNOL, V162, P3212
[6]  
Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO
[7]  
2-6
[8]   CP-10, a chemotactic peptide, is expressed in lesions of experimental autoimmune encephalomyelitis, neuritis, uveitis and in C6 gliomas [J].
Deininger, MH ;
Zhao, YH ;
Schluesener, HJ .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 93 (1-2) :156-163
[9]  
DEVERY JM, 1994, J IMMUNOL, V152, P1888
[10]  
Diacovo TG, 1996, BLOOD, V88, P146